We are live on ! Find out more
Dmitry Balyasny

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B Turnover 42.78%
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$3.01B
Cap. Flow %
-3.76%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.95%
2 Technology 12.69%
3 Industrials 9.95%
4 Consumer Discretionary 8.03%
5 Healthcare 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PGR icon
1476
PUT
Progressive
PGR
$134B
$3.56M ﹤0.01%
+16,300
New +$3.29M
2026 Q2
0 quarters
AVNT icon
1477
Avient
AVNT
$3.93B
$3.54M ﹤0.01%
95,908
-48,709
-34% -$1.76M
2025 Q3
3 quarters
GD icon
1478
CALL
General Dynamics
GD
$101B
$3.54M ﹤0.01%
+10,000
New +$3.43M
2026 Q2
0 quarters
ECG icon
1479
Everus Construction Group
ECG
$5.24B
$3.54M ﹤0.01%
21,336
+11,078
+108% +$1.62M
2025 Q4
2 quarters
HIMS icon
1480
PUT
Hims & Hers Health
HIMS
$6.46B
$3.54M ﹤0.01%
102,100
+80,900
+382% +$2.17M
2024 Q3
7 quarters
XOP icon
1481
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.35B
$3.54M ﹤0.01%
+22,938
New +$3.84M
2026 Q2
0 quarters
TER icon
1482
PUT
Teradyne
TER
$42.9B
$3.53M ﹤0.01%
7,300
+4,700
+181% +$1.77M
2026 Q1
1 quarter
CAVA icon
1483
PUT
CAVA Group
CAVA
$6.86B
$3.53M ﹤0.01%
45,000
-4,200
-9% -$352K
2025 Q3
3 quarters
JJSF icon
1484
J&J Snack Foods
JJSF
$1.6B
$3.53M ﹤0.01%
47,994
-71,507
-60% -$5.57M
2026 Q1
1 quarter
HNRG icon
1485
Hallador Energy
HNRG
$529M
$3.51M ﹤0.01%
202,042
+140,565
+229% +$2.42M
2026 Q1
1 quarter
TMO icon
1486
PUT
Thermo Fisher Scientific
TMO
$258B
$3.51M ﹤0.01%
7,000
+3,200
+84% +$1.54M
2023 Q2
12 quarters
ZS icon
1487
PUT
Zscaler
ZS
$38.8B
$3.5M ﹤0.01%
+24,800
New +$3.46M
2026 Q2
0 quarters
NKE icon
1488
CALL
Nike
NKE
$57.4B
$3.5M ﹤0.01%
85,200
+38,100
+81% +$1.68M
2022 Q2
16 quarters
CBOE icon
1489
PUT
Cboe Global Markets
CBOE
$35B
$3.49M ﹤0.01%
+14,400
New +$4.41M
2026 Q2
0 quarters
CDNS icon
1490
PUT
Cadence Design Systems
CDNS
$90B
$3.49M ﹤0.01%
9,300
-600
-6% -$210K
2025 Q1
5 quarters
VLO icon
1491
PUT
Valero Energy
VLO
$111B
$3.49M ﹤0.01%
13,400
-4,600
-26% -$1.13M
2023 Q3
11 quarters
JQC icon
1492
Nuveen Credit Strategies Income Fund
JQC
$681M
$3.48M ﹤0.01%
716,157
-99,369
-12% -$479K
2025 Q3
3 quarters
CXT icon
1493
Crane NXT
CXT
$3.37B
$3.48M ﹤0.01%
67,996
-136,003
-67% -$5.8M
2024 Q4
6 quarters
MRSH icon
1494
Marsh
MRSH
$95.4B
$3.47M ﹤0.01%
20,849
+8,361
+67% +$1.4M
2021 Q4
18 quarters
BBWI icon
1495
CALL
Bath & Body Works
BBWI
$4.59B
$3.47M ﹤0.01%
150,000
-75,000
-33% -$1.43M
2026 Q1
1 quarter
NU icon
1496
PUT
Nu Holdings
NU
$56.1B
$3.46M ﹤0.01%
258,700
– –
2025 Q2
4 quarters
WDC icon
1497
PUT
Western Digital
WDC
$137B
$3.45M ﹤0.01%
5,400
-4,300
-44% -$2.09M
2022 Q1
17 quarters
KLRA icon
1498
Kailera Therapeutics
KLRA
$1.67B
$3.41M ﹤0.01%
+154,838
New +$3.4M
2026 Q2
0 quarters
REYN icon
1499
Reynolds Consumer Products
REYN
$4.98B
$3.4M ﹤0.01%
126,704
-428,814
-77% -$9.6M
2024 Q3
7 quarters
NIQ icon
1500
NIQ Global Intelligence PLC
NIQ
$5.85B
$3.4M ﹤0.01%
+363,797
New +$3.52M
2026 Q2
0 quarters

Similar funds

Dmitry Balyasny's Q2 2026 Portfolio in Review

As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.

  • Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
  • Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.